Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
NCT ID: NCT00974610
Last Updated: 2017-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
803 participants
OBSERVATIONAL
2008-08-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This research study is looking at blood samples from patients with malignant melanoma, metastatic breast cancer, advanced lung cancer, pancreatic cancer, or colorectal cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781
Metabolic Phenotypes in Melanoma
NCT05570227
Collection of Blood From Patients With Cancer
NCT00034216
A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
NCT05574738
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* To assess which potential peptide and protein markers produced by human melanoma, lung, breast, pancreatic, and colorectal cell lines may be detectable in serum of patients from these five disease groups.
Secondary
* To conduct further extensive investigation with respect to identification of the protein/peptide involved, determination of specificity for each cancer, and development of more sensitive assays to look for such markers in a wider population of patients, including those undergoing therapy.
OUTLINE: This is a multicenter study.
Blood samples are collected before surgical intervention or treatment to assess peptide and protein markers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast
No interventions assigned to this group
Lung
No interventions assigned to this group
Melanoma
No interventions assigned to this group
Pancreatic
No interventions assigned to this group
Colorectal
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of 1 of the following advanced metastatic malignancies:
* Malignant melanoma
* Lung cancer
* Breast cancer
* Pancreatic carcinoma
* Colorectal cancer
* Advanced and/or metastatic disease
* Hormone receptor status not specified
PATIENT CHARACTERISTICS:
* Menopausal status not specified
PRIOR CONCURRENT THERAPY:
* Not specified
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cancer Trials Ireland
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Clynes
Role: PRINCIPAL_INVESTIGATOR
National Institute for Cellular Biotechnology at Dublin City University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cork University Hospital
Cork, , Ireland
Mercy University Hospital
Cork, , Ireland
Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital
Dublin, , Ireland
St. Vincent's University Hospital
Dublin, , Ireland
Mater Misericordiae University Hospital
Dublin, , Ireland
St. James's Hospital
Dublin, , Ireland
Beaumont Hospital
Dublin, , Ireland
Mater Private Hospital
Dublin, , Ireland
St Luke's Hospital
Dublin, , Ireland
University College Hospital
Galway, , Ireland
Letterkenny General Hospital
Letterkenny, , Ireland
Mid-Western Cancer Centre at Mid-Western Regional Hospital
Limerick, , Ireland
Waterford Regional Hospital
Waterford, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTRIAL-IE (ICORG) 07-12
Identifier Type: -
Identifier Source: secondary_id
EU-20949
Identifier Type: -
Identifier Source: secondary_id
CTRIAL-IE (ICORG) 07-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.